A phase II study of IMRT with concurrent chemotherapy for esophageal cancer with stage I
Phase 2
Recruiting
- Conditions
- superficial esophageal cancer
- Registration Number
- JPRN-UMIN000034668
- Lead Sponsor
- Tohoku Univeristy Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
Not provided
Exclusion Criteria
1.past EMR/ESD history for primary site 2.patient with intramural metastasis 3.past irradiation history for thoracic 4.patient with active malignant tumor 5.patient with severe complication 6.patient with active infection 7.patient with severe interstitial pneumonia 8.patient with ECD or pace maker
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 3-y progression-free survival rate
- Secondary Outcome Measures
Name Time Method Grade 2 or more adverse events and 3-y overall survival rate